EyePoint Pharmaceuticals
EYPT
#10613
Rank
S$34.37 M
Marketcap
S$0.30
Share price
-11.36%
Change (1 day)
-98.31%
Change (1 year)

EPS for EyePoint Pharmaceuticals (EYPT)

EPS in 2026 (TTM): S-$4.82

According to EyePoint Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S-$4.82. In 2025 the company made an earnings per share (EPS) of S-$4.08 a decrease over its 2024 EPS that were of S-$2.98.

EPS history for EyePoint Pharmaceuticals from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$4.8218.21%
2025S-$4.0836.8%
2024S-$2.98
2022S-$3.5235.15%
2021S-$2.61-42.45%
2020S-$4.53-37.32%
2019S-$7.22-57.89%
2018S-$17.16125.42%
2017S-$7.616.89%
2016S-$7.12-20.01%
2015S-$8.90
2013S-$7.2221.74%
2012S-$5.93-58.18%
2011S-$14.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
S-$0.07740-98.40% Bahamas
NRC Health
NRC
S$0.37-107.75%๐Ÿ‡บ๐Ÿ‡ธ USA